<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38203577</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>28</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Long COVID: Molecular Mechanisms and Detection Techniques.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">408</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25010408</ELocationID><Abstract><AbstractText>Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as a significant health concern following the COVID-19 pandemic. Molecular mechanisms underlying the occurrence and progression of long COVID include viral persistence, immune dysregulation, endothelial dysfunction, and neurological involvement, and highlight the need for further research to develop targeted therapies for this condition. While a clearer picture of the clinical symptomatology is shaping, many molecular mechanisms are yet to be unraveled, given their complexity and high level of interaction with other metabolic pathways. This review summarizes some of the most important symptoms and associated molecular mechanisms that occur in long COVID, as well as the most relevant molecular techniques that can be used in understanding the viral pathogen, its affinity towards the host, and the possible outcomes of host-pathogen interaction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Constantinescu-Bercu</LastName><ForeName>Adela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Biological Sciences, "&#x15e;tefan cel Mare" University of Suceava, 720229 Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobiuc</LastName><ForeName>Andrei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Biological Sciences, "&#x15e;tefan cel Mare" University of Suceava, 720229 Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C&#x103;liman-Sturdza</LastName><ForeName>Olga Adriana</ForeName><Initials>OA</Initials><Identifier Source="ORCID">0000-0003-2274-6439</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Biological Sciences, "&#x15e;tefan cel Mare" University of Suceava, 720229 Suceava, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Suceava Emergency Clinical County Hospital, 720224 Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oi&#x163;&#x103;</LastName><ForeName>Radu Cristian</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Integrated Center for Research, Development and Innovation for Advanced Materials, Nanotechnologies, Manufacturing and Control Distributed Systems (MANSiD), &#x15e;tefan cel Mare University of Suceava, 720229 Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iavorschi</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Biological Sciences, "&#x15e;tefan cel Mare" University of Suceava, 720229 Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pav&#x103;l</LastName><ForeName>Naomi-Eunicia</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Biological Sciences, "&#x15e;tefan cel Mare" University of Suceava, 720229 Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x218;old&#x103;nescu</LastName><ForeName>Iuliana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Integrated Center for Research, Development and Innovation for Advanced Materials, Nanotechnologies, Manufacturing and Control Distributed Systems (MANSiD), &#x15e;tefan cel Mare University of Suceava, 720229 Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimian</LastName><ForeName>Mihai</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2093-8659</Identifier><AffiliationInfo><Affiliation>Integrated Center for Research, Development and Innovation for Advanced Materials, Nanotechnologies, Manufacturing and Control Distributed Systems (MANSiD), &#x15e;tefan cel Mare University of Suceava, 720229 Suceava, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computers, Electronics and Automation, &#x15e;tefan cel Mare University of Suceava, 720229 Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covasa</LastName><ForeName>Mihai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Medicine and Biological Sciences, "&#x15e;tefan cel Mare" University of Suceava, 720229 Suceava, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Basic Medical Sciences, College of Osteopathic Medicine, Western University of Health Sciences, Pomona, CA 91711, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PN-III-Pl-1.1-PD-2021-0273, within PNCDI III</GrantID><Agency>Ministry of Research, Innovation and Digitization, CNCS - UEFISCDI</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">gene expression</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">sequencing</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>7</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38203577</ArticleId><ArticleId IdType="pmc">PMC10778767</ArticleId><ArticleId IdType="doi">10.3390/ijms25010408</ArticleId><ArticleId IdType="pii">ijms25010408</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A., Vasaikar S.V., Szeto G.L., Lemos M.P., Czartoski J.L., MacMillan H., Moodie Z., Cohen K.W., Fleming L.B., Thomson Z., et al. Persistent serum protein signatures define an inflammatory subcategory of long COVID. Nat. Commun. 2023;14:3417. doi: 10.1038/s41467-023-38682-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38682-4</ArticleId><ArticleId IdType="pmc">PMC10252177</ArticleId><ArticleId IdType="pubmed">37296110</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n E., Yang C., Shannon C.P., Assadian S., He D., Tebbutt S.J. Cellular and molecular biomarkers of long COVID: A scoping review. eBioMedicine. 2023;91:104552. doi: 10.1016/j.ebiom.2023.104552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopplin N., Garcia A., Reczek A., Wilkinson K., Yekkaluri S., Murphy C.C., Tiro J., Muthukumar A.R., Masica A., Singal A.G. Post-acute sequelae of COVID-19 and longitudinal antibody levels in a community-based cohort. PLoS ONE. 2023;18:e0291259. doi: 10.1371/journal.pone.0291259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0291259</ArticleId><ArticleId IdType="pmc">PMC10490864</ArticleId><ArticleId IdType="pubmed">37682916</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitroi R., Padureanu V., Mitrea A., Protasiewicz Timofticiuc D.C., Rosu M.M., Clenciu D., Enescu A., Padureanu R., Tenea Cojan T.S., Vladu I.M. Prothrombotic status in COVID-19 with diabetes mellitus (Review) Biomed. Rep. 2023;19:65. doi: 10.3892/br.2023.1647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2023.1647</ArticleId><ArticleId IdType="pmc">PMC10463232</ArticleId><ArticleId IdType="pubmed">37649534</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss A.B., Greene C., Dayaramani C., Rauchman S.H., Stecker M.M., De Leon J., Pinkhasov A. Long COVID, the Brain, Nerves, and Cognitive Function. Neurol. Int. 2023;15:821&#x2013;841. doi: 10.3390/neurolint15030052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15030052</ArticleId><ArticleId IdType="pmc">PMC10366776</ArticleId><ArticleId IdType="pubmed">37489358</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Flamier A., Bisht P., Richards A., Tomasello D.L., Jaenisch R. Human iPS cell-derived sensory neurons can be infected by SARS-CoV-2. iScience. 2023;26:107690. doi: 10.1016/j.isci.2023.107690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.107690</ArticleId><ArticleId IdType="pmc">PMC10480666</ArticleId><ArticleId IdType="pubmed">37680484</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A., Shah M., Ahmad S.A., Premraj L., Wildi K., Li Bassi G., Pardo C.A., Choi A., Cho S.-M. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells. 2023;12:816. doi: 10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibert F.S., Stervbo U., Wiemers L., Skrzypczyk S., Hogeweg M., Bertram S., Kurek J., Anft M., Westhoff T.H., Babel N. Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors. Autoimmun. Rev. 2023;22:103445. doi: 10.1016/j.autrev.2023.103445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2023.103445</ArticleId><ArticleId IdType="pubmed">37689093</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Langton D.J., Bourke S.C., Lie B.A., Reiff G., Natu S., Darlay R., Burn J., Echevarria C. The influence of HLA genotype on the severity of COVID-19 infection. HLA. 2021;98:14&#x2013;22. doi: 10.1111/tan.14284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.14284</ArticleId><ArticleId IdType="pmc">PMC8251294</ArticleId><ArticleId IdType="pubmed">33896121</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Francisco E.B., Yogendra R., Long E., Pise A., Rodrigues H., Hall E., Herrera M., Parikh P., Guevara-Coto J., et al. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front. Immunol. 2022;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M., Liu Y., Yuan J., Wen Y., Xu G., Zhao J., Cheng L., Li J., Wang X., Wang F., et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 2020;26:842&#x2013;844. doi: 10.1038/s41591-020-0901-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0901-9</ArticleId><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N., P&#xe9;r&#xe9; H., Charbit B., Bondet V., Chenevier-Gobeaux C., et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718&#x2013;724. doi: 10.1126/science.abc6027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S., Kim L., Whitaker M., O&#x2019;Halloran A., Cummings C., Holstein R., Prill M., Chai S.J., Kirley P.D., Alden N.B., et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019&#x2013;COVID-NET, 14 States, March 1&#x2013;30, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:458&#x2013;464. doi: 10.15585/mmwr.mm6915e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6915e3</ArticleId><ArticleId IdType="pmc">PMC7755063</ArticleId><ArticleId IdType="pubmed">32298251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.-Y., Whalley J.P., Knight J.C., Wicker L.S., Todd J.A., Ferreira R.C. SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile. Genome Med. 2023;15:69. doi: 10.1186/s13073-023-01227-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-023-01227-x</ArticleId><ArticleId IdType="pmc">PMC10498514</ArticleId><ArticleId IdType="pubmed">37700317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Park S., Jeong H.W., Ahn J.Y., Choi S.J., Lee H., Choi B., Nam S.K., Sa M., Kwon J.-S., et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 2020;5:eabd1554. doi: 10.1126/sciimmunol.abd1554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd1554</ArticleId><ArticleId IdType="pmc">PMC7402635</ArticleId><ArticleId IdType="pubmed">32651212</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnacker S., Hartung F., Henkel F., Quaranta A., Kolmert J., Priller A., Ud-Dean M., Giglberger J., Kugler L.M., Pechtold L., et al. Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages. Mucosal Immunol. 2022;15:515&#x2013;524. doi: 10.1038/s41385-021-00482-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00482-8</ArticleId><ArticleId IdType="pmc">PMC9038526</ArticleId><ArticleId IdType="pubmed">35288643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K., Peluso M.J., Luo X., Thomas R., Shin M.-G., Neidleman J., Andrew A., Young K., Ma T., Hoh R., et al. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv. 2023. preprint .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Santopaolo M., Gregorova M., Hamilton F., Arnold D., Long A., Lacey A., Oliver E., Halliday A., Baum H., Hamilton K., et al. Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months. eLife. 2023;12:e85009. doi: 10.7554/eLife.85009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.85009</ArticleId><ArticleId IdType="pmc">PMC10319436</ArticleId><ArticleId IdType="pubmed">37310006</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooq M., Khan A.W., Kim M.S., Choi S. The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration. Cells. 2021;10:3242. doi: 10.3390/cells10113242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10113242</ArticleId><ArticleId IdType="pmc">PMC8622657</ArticleId><ArticleId IdType="pubmed">34831463</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Luo S., Qin R., Yang M., Wang X., Yang Q., Zhang Y., Wang Q., Zhu R., Fan H., et al. Long-term infection of SARS-CoV-2 changed the body&#x2019;s immune status. Clin. Immunol. 2020;218:108524. doi: 10.1016/j.clim.2020.108524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108524</ArticleId><ArticleId IdType="pmc">PMC7351676</ArticleId><ArticleId IdType="pubmed">32659373</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhshandeh B., Sorboni S.G., Javanmard A.-R., Mottaghi S.S., Mehrabi M., Sorouri F., Abbasi A., Jahanafrooz Z. Variants in ACE2; potential influences on virus infection and COVID-19 severity. Infect. Genet. Evol. 2021;90:104773. doi: 10.1016/j.meegid.2021.104773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.104773</ArticleId><ArticleId IdType="pmc">PMC7886638</ArticleId><ArticleId IdType="pubmed">33607284</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;hlendick B., Sch&#xf6;nfelder K., Breuckmann K., Elsner C., Babel N., Balfanz P., Dahl E., Dreher M., Fistera D., Herbstreit F., et al. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19. Pharmacogenet. Genom. 2021;31:165&#x2013;171. doi: 10.1097/FPC.0000000000000436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FPC.0000000000000436</ArticleId><ArticleId IdType="pmc">PMC8415730</ArticleId><ArticleId IdType="pubmed">34001841</ArticleId></ArticleIdList></Reference><Reference><Citation>Paruchuri S.S.H., Farwa U.E., Jabeen S., Pamecha S., Shan Z., Parekh R., Lakkimsetti M., Alamin E., Sharma V., Haider S., et al. Myocarditis and Myocardial Injury in Long COVID Syndrome: A Comprehensive Review of the Literature. Cureus. 2023;15:e42444. doi: 10.7759/cureus.42444.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.42444</ArticleId><ArticleId IdType="pmc">PMC10449234</ArticleId><ArticleId IdType="pubmed">37637608</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi P., Huang M., Zhu H. Exploring potential biomarkers and therapeutic targets of long COVID-associated inflammatory cardiomyopathy. Front. Med. 2023;10:1191354. doi: 10.3389/fmed.2023.1191354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1191354</ArticleId><ArticleId IdType="pmc">PMC10346863</ArticleId><ArticleId IdType="pubmed">37457560</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.-H., Wood J., O&#x2019;Dea M.R., Dutton S., Shamardani K., Nwangwu K., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e16. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Skorniewska Z., Hampshire A., Chalmers J.D., Ho L.-P., Horsley A., Marks M., Poinasamy K., Raman B., Leavy O.C., et al. Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. Nat. Med. 2023;29:2498&#x2013;2508. doi: 10.1038/s41591-023-02525-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02525-y</ArticleId><ArticleId IdType="pmc">PMC10579097</ArticleId><ArticleId IdType="pubmed">37653345</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y.-J., Liu S.-H., Manachevakul S., Lee T.-A., Kuo C.-T., Bello D. Biomarkers in long COVID-19: A systematic review. Front. Med. 2023;10:1085988. doi: 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Sans H.M., Forman C.A., Nylander A.N., Ho H., Lu S., Goldberg S.A., Hoh R., Tai V., Munter S.E., et al. Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e200003. doi: 10.1212/NXI.0000000000200003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200003</ArticleId><ArticleId IdType="pmc">PMC9210548</ArticleId><ArticleId IdType="pubmed">35701186</ArticleId></ArticleIdList></Reference><Reference><Citation>Green R., Mayilsamy K., McGill A.R., Martinez T.E., Chandran B., Blair L.J., Bickford P.C., Mohapatra S.S., Mohapatra S. SARS-CoV-2 infection increases the gene expression profile for Alzheimer&#x2019;s disease risk. Mol. Ther.-Methods Clin. Dev. 2022;27:217&#x2013;229. doi: 10.1016/j.omtm.2022.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2022.09.007</ArticleId><ArticleId IdType="pmc">PMC9508696</ArticleId><ArticleId IdType="pubmed">36187720</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A., Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 2020;16:636&#x2013;644. doi: 10.1038/s41582-020-0398-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0398-3</ArticleId><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Long S., Cort&#xe9;s-Altamirano J.L., Bandala C., Avenda&#xf1;o-Ortiz K., Bonilla-Jaime H., Bueno-Nava A., &#xc1;vila-Luna A., S&#xe1;nchez-Aparicio P., Clavijo-Cornejo D., Dotor-Llerena A.L. Role of the MicroRNAs in the Pathogenic Mechanism of Painful Symptoms in Long COVID. Syst. Rev. Int. J. Mol. Sci. 2023;24:3574. doi: 10.3390/ijms24043574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043574</ArticleId><ArticleId IdType="pmc">PMC9963913</ArticleId><ArticleId IdType="pubmed">36834984</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay M.Z., Poh C.M., R&#xe9;nia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: Immunity, inflammation and intervention. Nat. Rev. Immunol. 2020;20:363&#x2013;374. doi: 10.1038/s41577-020-0311-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Yang X.O. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. J. Microbiol. Immunol. Infect. 2020;53:368&#x2013;370. doi: 10.1016/j.jmii.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.03.005</ArticleId><ArticleId IdType="pmc">PMC7156211</ArticleId><ArticleId IdType="pubmed">32205092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T.B.R., Silva J., Sundaram M., Ellingson M.K., Mao T., Oh J.E., Israelow B., et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463&#x2013;469. doi: 10.1038/s41586-020-2588-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Widiasta A., Sribudiani Y., Nugrahapraja H., Hilmanto D., Sekarwana N., Rachmadi D. Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy. Non-Coding RNA Res. 2020;5:153&#x2013;166. doi: 10.1016/j.ncrna.2020.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2020.09.001</ArticleId><ArticleId IdType="pmc">PMC7480227</ArticleId><ArticleId IdType="pubmed">32923747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D.C., June C.H. Cytokine Storm. N. Engl. J. Med. 2020;383:2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8:420&#x2013;422. doi: 10.1016/S2213-2600(20)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuri-Cervantes L., Pampena M.B., Meng W., Rosenfeld A.M., Ittner C.A.G., Weisman A.R., Agyekum R.S., Mathew D., Baxter A.E., Vella L.A., et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci. Immunol. 2020;5:eabd7114. doi: 10.1126/sciimmunol.abd7114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd7114</ArticleId><ArticleId IdType="pmc">PMC7402634</ArticleId><ArticleId IdType="pubmed">32669287</ArticleId></ArticleIdList></Reference><Reference><Citation>Trogstad L., Laake I., Robertson A.H., Mjaaland S., Caspersen I.H., Juvet L.K., Magnus P., Blix K., Feiring B. Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination. Vaccine. 2023;41:5271&#x2013;5282. doi: 10.1016/j.vaccine.2023.06.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.06.088</ArticleId><ArticleId IdType="pubmed">37451876</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Chen G., Hou H., Liao Q., Chen J., Bai H., Lee S., Wang C., Li H., Cheng L., et al. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod. BioMed. Online. 2021;42:260&#x2013;267. doi: 10.1016/j.rbmo.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7522626</ArticleId><ArticleId IdType="pubmed">33288478</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenbaum E.E., Hartel D., Lo Y., Howard A.A., Floris-Moore M., Arnsten J.H., Santoro N. HIV Infection, Drug Use, and Onset of Natural Menopause. Clin. Infect. Dis. 2005;41:1517&#x2013;1524. doi: 10.1086/497270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/497270</ArticleId><ArticleId IdType="pubmed">16231267</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjo R., Momani E., Sabbah D.A., Baker N., Tropsha A. Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes. npj Vaccines. 2023;8:129. doi: 10.1038/s41541-023-00719-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-023-00719-6</ArticleId><ArticleId IdType="pmc">PMC10474200</ArticleId><ArticleId IdType="pubmed">37658087</ArticleId></ArticleIdList></Reference><Reference><Citation>Udomsinprasert W., Nontawong N., Saengsiwaritt W., Panthan B., Jiaranai P., Thongchompoo N., Santon S., Runcharoen C., Sensorn I., Jittikoon J., et al. Host genetic polymorphisms involved in long-term symptoms of COVID-19. Emerg. Microbes Infect. 2023;12:2239952. doi: 10.1080/22221751.2023.2239952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2239952</ArticleId><ArticleId IdType="pmc">PMC10392286</ArticleId><ArticleId IdType="pubmed">37497655</ArticleId></ArticleIdList></Reference><Reference><Citation>Downes D.J., Cross A.R., Hua P., Roberts N., Schwessinger R., Cutler A.J., Munis A.M., Brown J., Mielczarek O., De Andrea C.E., et al. Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus. Nat. Genet. 2021;53:1606&#x2013;1615. doi: 10.1038/s41588-021-00955-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00955-3</ArticleId><ArticleId IdType="pmc">PMC7611960</ArticleId><ArticleId IdType="pubmed">34737427</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoni D., Ghosh N., Derelitto C., Saha I. Transcription Factor Driven Gene Regulation in COVID-19 Patients. Viruses. 2023;15:1188. doi: 10.3390/v15051188.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15051188</ArticleId><ArticleId IdType="pmc">PMC10223727</ArticleId><ArticleId IdType="pubmed">37243274</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrysanthopoulou A., Antoniadou C., Natsi A.-M., Gavriilidis E., Papadopoulos V., Xingi E., Didaskalou S., Mikroulis D., Tsironidou V., Kambas K., et al. Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signaling. Clin. Immunol. 2023;247:109240. doi: 10.1016/j.clim.2023.109240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2023.109240</ArticleId><ArticleId IdType="pmc">PMC9862710</ArticleId><ArticleId IdType="pubmed">36693535</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Liu Y., Ding Y., Luo S., Zheng X., Wu X., Liu Z., Ilyas I., Chen S., Han S., et al. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduct. Target. Ther. 2021;6:266. doi: 10.1038/s41392-021-00690-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00690-5</ArticleId><ArticleId IdType="pmc">PMC8273371</ArticleId><ArticleId IdType="pubmed">34253708</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahjaman M., Rezanur Rahman M., Rabiul Auwul M. A network-based systems biology approach for identification of shared Gene signatures between male and female in COVID-19 datasets. Inform. Med. Unlocked. 2021;25:100702. doi: 10.1016/j.imu.2021.100702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imu.2021.100702</ArticleId><ArticleId IdType="pmc">PMC8372456</ArticleId><ArticleId IdType="pubmed">34423108</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou J., Wei Y., Zou J., Jaffery R., Liang S., Zheng C., Chen K., Shi P.-Y., Chen Y., Xie X., et al. Integrated multi-omics analyses identify key anti-viral host factors and pathways controlling SARS-CoV-2 infection. Res. Sq. 2022. preprint .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10761986</ArticleId><ArticleId IdType="pubmed">38168026</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw R.J., Bradbury C., Abrams S.T., Wang G., Toh C. COVID-19 and immunothrombosis: Emerging understanding and clinical management. Br. J. Haematol. 2021;194:518&#x2013;529. doi: 10.1111/bjh.17664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17664</ArticleId><ArticleId IdType="pubmed">34114204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji W., Chen L., Yang W., Li K., Zhao J., Yan C., You C., Jiang M., Zhou M., Shen X. Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: Implications for immunothrombosis. Cell Biosci. 2022;12:15. doi: 10.1186/s13578-022-00750-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-022-00750-5</ArticleId><ArticleId IdType="pmc">PMC8827164</ArticleId><ArticleId IdType="pubmed">35139909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolny M., Rozanova S., Knabbe C., Pfeiffer K., Barkovits K., Marcus K., Birschmann I. Changes in the Proteome of Platelets from Patients with Critical Progression of COVID-19. Cells. 2023;12:2191. doi: 10.3390/cells12172191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12172191</ArticleId><ArticleId IdType="pmc">PMC10486756</ArticleId><ArticleId IdType="pubmed">37681923</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett T.J., Cornwell M., Myndzar K., Rolling C.C., Xia Y., Drenkova K., Biebuyck A., Fields A.T., Tawil M., Luttrell-Williams E., et al. Platelets amplify endotheliopathy in COVID-19. Sci. Adv. 2021;7:eabh2434. doi: 10.1126/sciadv.abh2434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abh2434</ArticleId><ArticleId IdType="pmc">PMC8442885</ArticleId><ArticleId IdType="pubmed">34516880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammi V., Nakanishi T., Jones S.E., Andrews S.J., Karjalainen J., Cort&#xe9;s B., O&#x2019;Brien H.E., Fulton-Howard B.E., Haapaniemi H.H., Schmidt A., et al. Genome-wide Association Study of Long COVID. medRxiv. 2023. preprint .</Citation></Reference><Reference><Citation>Ferreira L.C., Gomes C.E.M., Rodrigues-Neto J.F., Jeronimo S.M.B. Genome-wide association studies of COVID-19: Connecting the dots. Infect. Genet. Evol. 2022;106:105379. doi: 10.1016/j.meegid.2022.105379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2022.105379</ArticleId><ArticleId IdType="pmc">PMC9584840</ArticleId><ArticleId IdType="pubmed">36280088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiehagen K.R., Corbo-Rodgers E., Li S., Staub E.S., Hunter C.A., Morrisey E.E., Maltzman J.S. Foxp4 Is Dispensable for T Cell Development, but Required for Robust Recall Responses. PLoS ONE. 2012;7:e42273. doi: 10.1371/journal.pone.0042273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0042273</ArticleId><ArticleId IdType="pmc">PMC3418275</ArticleId><ArticleId IdType="pubmed">22912696</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Giralt N., Du J., Marin-Corral J., B&#xf3;dalo-Torruella M., Blasco-Hernando F., Mu&#xf1;oz-Berm&#xfa;dez R., Clar&#xf3;s M., Nonell L., Perera-Bel J., Fernandez-Gonz&#xe1;lez M., et al. Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection. Sci. Rep. 2022;12:6929. doi: 10.1038/s41598-022-10738-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10738-3</ArticleId><ArticleId IdType="pmc">PMC9047579</ArticleId><ArticleId IdType="pubmed">35484171</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Sun Q., Zhang B., Zhao W., Shen C. The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection. Front. Cell Dev. Biol. 2023;11:1229393. doi: 10.3389/fcell.2023.1229393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2023.1229393</ArticleId><ArticleId IdType="pmc">PMC10416254</ArticleId><ArticleId IdType="pubmed">37576600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K.C., Chang H.Y. Molecular Mechanisms of Long Noncoding RNAs. Mol. Cell. 2011;43:904&#x2013;914. doi: 10.1016/j.molcel.2011.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.08.018</ArticleId><ArticleId IdType="pmc">PMC3199020</ArticleId><ArticleId IdType="pubmed">21925379</ArticleId></ArticleIdList></Reference><Reference><Citation>Arun G., Aggarwal D., Spector D.L. MALAT1 Long Non-Coding RNA: Functional Implications. ncRNA. 2020;6:22. doi: 10.3390/ncrna6020022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna6020022</ArticleId><ArticleId IdType="pmc">PMC7344863</ArticleId><ArticleId IdType="pubmed">32503170</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey S., Ashwin H., Milross L., Hunter B., Majo J., Filby A.J., Fisher A.J., Kaye P.M., Lagos D. Downregulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19. Clin. Exp. Immunol. 2023;212:262&#x2013;275. doi: 10.1093/cei/uxad034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cei/uxad034</ArticleId><ArticleId IdType="pmc">PMC10243916</ArticleId><ArticleId IdType="pubmed">36869729</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K., Wang C., Vagts C., Raguveer V., Finn P.W., Perkins D.L. Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis. PLoS ONE. 2022;17:e0261242. doi: 10.1371/journal.pone.0261242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261242</ArticleId><ArticleId IdType="pmc">PMC8746747</ArticleId><ArticleId IdType="pubmed">35007307</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai L., Zhang G., Cheng Z., Wang X., Jia L., Jing X., Wang H., Zhang R., Liu M., Jiang T., et al. Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury. Connect. Tissue Res. 2018;59:581&#x2013;592. doi: 10.1080/03008207.2018.1439480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03008207.2018.1439480</ArticleId><ArticleId IdType="pubmed">29649906</ArticleId></ArticleIdList></Reference><Reference><Citation>Knutsen E., Harris A.L., Perander M. Expression and functions of long non-coding RNA NEAT1 and isoforms in breast cancer. Br. J. Cancer. 2022;126:551&#x2013;561. doi: 10.1038/s41416-021-01588-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-021-01588-3</ArticleId><ArticleId IdType="pmc">PMC8854383</ArticleId><ArticleId IdType="pubmed">34671127</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayel S.I., El-Masry E.A., Abdelaal G.A., Shehab-Eldeen S., Essa A., Muharram N.M. Interplay of LncRNAs NEAT1 and TUG1 in Incidence of Cytokine Storm in Appraisal of COVID-19 Infection. Int. J. Biol. Sci. 2022;18:4901&#x2013;4913. doi: 10.7150/ijbs.72318.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.72318</ArticleId><ArticleId IdType="pmc">PMC9379411</ArticleId><ArticleId IdType="pubmed">35982898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues A.C., Adamoski D., Genelhould G., Zhen F., Yamaguto G.E., Araujo-Souza P.S., Nogueira M.B., Raboni S.M., Bonatto A.C., Gradia D.F. NEAT1 and MALAT1 are highly expressed in saliva and nasopharyngeal swab samples of COVID-19 patients. Mol. Oral. Microbiol. 2021;36:291&#x2013;294. doi: 10.1111/omi.12351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/omi.12351</ArticleId><ArticleId IdType="pmc">PMC8661855</ArticleId><ArticleId IdType="pubmed">34463043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Cao L., Zhou R., Yang X., Wu M. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nat. Commun. 2019;10:1495. doi: 10.1038/s41467-019-09482-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09482-6</ArticleId><ArticleId IdType="pmc">PMC6445148</ArticleId><ArticleId IdType="pubmed">30940803</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.-E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi-Kolli M., Nahand J.S., Kiani S.J., Khanaliha K., Khatami A., Taghizadieh M., Torkamani A.R., Babakhaniyan K., Bokharaei-Salim F. The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease. Braz. J. Infect. Dis. 2022;26:102354. doi: 10.1016/j.bjid.2022.102354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2022.102354</ArticleId><ArticleId IdType="pmc">PMC9035361</ArticleId><ArticleId IdType="pubmed">35500644</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J., Zhou X., Feng W., Jia M., Zhang X., An T., Luan M., Pan Y., Zhang S., Zhou Z. Risk stratification by long non-coding RNAs profiling in COVID-19 patients. J. Cell. Mol. Med. 2021;25:4753&#x2013;4764. doi: 10.1111/jcmm.16444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16444</ArticleId><ArticleId IdType="pmc">PMC8107096</ArticleId><ArticleId IdType="pubmed">33759345</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield K.M., Watson R.O., Schneider J.M., Neff C.P., Yamada E., Zhang M., Campbell T.B., Falta M.T., Jolley S.E., Fontenot A.P., et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022;18:e1010359. doi: 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deeks S.G., Mustapic M., Kapogiannis D., Henrich T.J., Lu S., Goldberg S.A., Hoh R., Chen J.Y., Martinez E.O., et al. SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19. Ann. Neurol. 2022;91:772&#x2013;781. doi: 10.1002/ana.26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N., Khodayari Y., Hosseinian-Far A., Zarei H., Rasoulpoor S., Akbari H., Mohammadi M. Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis. BioPsychoSoc. Med. 2022;16:21. doi: 10.1186/s13030-022-00250-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13030-022-00250-5</ArticleId><ArticleId IdType="pmc">PMC9589726</ArticleId><ArticleId IdType="pubmed">36274177</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., Leavy O.C., Richardson M., Elneima O., McAuley H.J.C., Shikotra A., Singapuri A., Sereno M., Saunders R.M., Harris V.C., et al. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: A prospective observational study. Lancet Respir. Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020;159:944&#x2013;955.e8. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding G., Shao Q., Yu H., Liu J., Li Y., Wang B., Sang H., Li D., Bing A., Hou Y., et al. Tight Junctions, the Key Factor in Virus-Related Disease. Pathogens. 2022;11:1200. doi: 10.3390/pathogens11101200.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11101200</ArticleId><ArticleId IdType="pmc">PMC9611889</ArticleId><ArticleId IdType="pubmed">36297257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Aenlle K.K., Cohen J., Mathew A., Isler D., Pangeni R.P., Nathanson L., Theoharides T.C., Klimas N.G. COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions. Neuroscientist. 2023:10738584231194927. doi: 10.1177/10738584231194927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10738584231194927</ArticleId><ArticleId IdType="pubmed">37694571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Yang W., Roy S., Liu H., Roberts R.M., Wang L., Shi L., Ma W. Tight junction protein occludin is an internalization factor for SARS-CoV-2 infection and mediates virus cell-to-cell transmission. Proc. Natl. Acad. Sci. USA. 2023;120:e2218623120. doi: 10.1073/pnas.2218623120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2218623120</ArticleId><ArticleId IdType="pmc">PMC10151465</ArticleId><ArticleId IdType="pubmed">37068248</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende S., Parikh C.R. Long COVID and kidney disease. Nat. Rev. Nephrol. 2021;17:792&#x2013;793. doi: 10.1038/s41581-021-00487-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00487-3</ArticleId><ArticleId IdType="pmc">PMC8427150</ArticleId><ArticleId IdType="pubmed">34504319</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H., Karp Leaf R.S., Dzik W.H., Carlson J.C.T., Fogerty A.E., Waheed A., Goodarzi K., Bendapudi P.K., Bornikova L., Gupta S., et al. COVID-19 and coagulation: Bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136:489&#x2013;500. doi: 10.1182/blood.2020006520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006520</ArticleId><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobs K., Reinshagen L., Puccini M., Friebel J., Wilde A.-C.B., Alsheik A., Rroku A., Landmesser U., Haghikia A., Kr&#xe4;nkel N., et al. Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation. Front. Immunol. 2022;13:844701. doi: 10.3389/fimmu.2022.844701.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.844701</ArticleId><ArticleId IdType="pmc">PMC8963244</ArticleId><ArticleId IdType="pubmed">35359931</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Gon&#xe7;alves R., Campos M.M., Palhinha L., Azevedo-Quintanilha I.G., Abud Mendes M., Ramos Temerozo J., Toledo-Mendes J., Rosado-de-Castro P.H., Bozza F.A., Souza Rodrigues R., et al. Persisting Platelet Activation and Hyperactivity in COVID-19 Survivors. Circ. Res. 2022;131:944&#x2013;947. doi: 10.1161/CIRCRESAHA.122.321659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321659</ArticleId><ArticleId IdType="pmc">PMC9645447</ArticleId><ArticleId IdType="pubmed">36268747</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Xu X., Gao Y., Yu Y., Li C. Crosstalk between Platelets and SARS-CoV-2: Implications in Thrombo-Inflammatory Complications in COVID-19. Int. J. Mol. Sci. 2023;24:14133. doi: 10.3390/ijms241814133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241814133</ArticleId><ArticleId IdType="pmc">PMC10531760</ArticleId><ArticleId IdType="pubmed">37762435</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne B.K., Denorme F., Middleton E.A., Portier I., Rowley J.W., Stubben C., Petrey A.C., Tolley N.D., Guo L., Cody M., et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136:1317&#x2013;1329. doi: 10.1182/blood.2020007214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007214</ArticleId><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow J.H., Khanna A.K., Kethireddy S., Yamane D., Levine A., Jackson A.M., McCurdy M.T., Tabatabai A., Kumar G., Park P., et al. Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019. Anesth. Analg. 2021;132:930&#x2013;941. doi: 10.1213/ANE.0000000000005292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005292</ArticleId><ArticleId IdType="pubmed">33093359</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizlish M.L., Goshua G., Liu Y., Fine R., Amin K., Chang E., DeFilippo N., Keating C., Liu Y., Mankbadi M., et al. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis. Am. J. Hematol. 2021;96:471&#x2013;479. doi: 10.1002/ajh.26102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26102</ArticleId><ArticleId IdType="pmc">PMC8013588</ArticleId><ArticleId IdType="pubmed">33476420</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L., Kaiser R., Stark K. Thromboinflammation in long COVID&#x2014;the elusive key to postinfection sequelae? J. Thromb. Haemost. 2023;21:2020&#x2013;2031. doi: 10.1016/j.jtha.2023.04.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2023.04.039</ArticleId><ArticleId IdType="pmc">PMC10174338</ArticleId><ArticleId IdType="pubmed">37178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Mereweather L.J., Constantinescu-Bercu A., Crawley J.T.B., Salles-Crawley I.I. Platelet&#x2013;Neutrophil Crosstalk in Thrombosis. Int. J. Mol. Sci. 2023;24:1266. doi: 10.3390/ijms24021266.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021266</ArticleId><ArticleId IdType="pmc">PMC9861587</ArticleId><ArticleId IdType="pubmed">36674781</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch J., Uzun G., Zlamal J., Singh A., Bakchoul T. Platelet-neutrophil interaction in COVID-19 and vaccine-induced thrombotic thrombocytopenia. Front. Immunol. 2023;14:1186000. doi: 10.3389/fimmu.2023.1186000.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1186000</ArticleId><ArticleId IdType="pmc">PMC10237318</ArticleId><ArticleId IdType="pubmed">37275917</ArticleId></ArticleIdList></Reference><Reference><Citation>Canzano P., Brambilla M., Porro B., Cosentino N., Tortorici E., Vicini S., Poggio P., Cascella A., Pengo M.F., Veglia F., et al. Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients. JACC Basic. Transl. Sci. 2021;6:202&#x2013;218. doi: 10.1016/j.jacbts.2020.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7904280</ArticleId><ArticleId IdType="pubmed">33649738</ArticleId></ArticleIdList></Reference><Reference><Citation>Taus F., Salvagno G., Can&#xe8; S., Fava C., Mazzaferri F., Carrara E., Petrova V., Barouni R.M., Dima F., Dalbeni A., et al. Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia. Arterioscler. Thromb. Vasc. Biol. 2020;40:2975&#x2013;2989. doi: 10.1161/ATVBAHA.120.315175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315175</ArticleId><ArticleId IdType="pmc">PMC7682791</ArticleId><ArticleId IdType="pubmed">33052054</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y., Puhm F., Allaeys I., Naya A., Oudghiri M., Khalki L., Limami Y., Zaid N., Sadki K., Ben El Haj R., et al. Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19. Circ. Res. 2020;127:1404&#x2013;1418. doi: 10.1161/CIRCRESAHA.120.317703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317703</ArticleId><ArticleId IdType="pmc">PMC7641188</ArticleId><ArticleId IdType="pubmed">32938299</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:1421&#x2013;1424. doi: 10.1111/jth.14830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14830</ArticleId><ArticleId IdType="pmc">PMC7262324</ArticleId><ArticleId IdType="pubmed">32271988</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervaise A., Bouzad C., Peroux E., Helissey C. Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department. Eur. Radiol. 2020;30:6170&#x2013;6177. doi: 10.1007/s00330-020-06977-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-06977-5</ArticleId><ArticleId IdType="pmc">PMC7280685</ArticleId><ArticleId IdType="pubmed">32518989</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan B.E., Wong S.W., Sum C.L.L., Lim G.H., Leung B.P., Tan C.W., Ramanathan K., Dalan R., Cheung C., Lim X.R., et al. Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: Assessing the long-term outcomes in COVID -19 patients. Am. J. Hematol. 2022;97:915&#x2013;923. doi: 10.1002/ajh.26575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26575</ArticleId><ArticleId IdType="pmc">PMC9073976</ArticleId><ArticleId IdType="pubmed">35477923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M., Baryshnikova E., Anguissola M., Pugliese S., Falco M., Menicanti L. The Long Term Residual Effects of COVID-Associated Coagulopathy. Int. J. Mol. Sci. 2023;24:5514. doi: 10.3390/ijms24065514.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065514</ArticleId><ArticleId IdType="pmc">PMC10049638</ArticleId><ArticleId IdType="pubmed">36982589</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway E.M., Mackman N., Warren R.Q., Wolberg A.S., Mosnier L.O., Campbell R.A., Gralinski L.E., Rondina M.T., Van De Veerdonk F.L., Hoffmeister K.M., et al. Understanding COVID-19-associated coagulopathy. Nat. Rev. Immunol. 2022;22:639&#x2013;649. doi: 10.1038/s41577-022-00762-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Karampini E., O&#x2019;Donnell A.S., Ward S.E., O&#x2019;Sullivan J.M., O&#x2019;Donnell J.S. The Irish COVID-19 Vasculopathy Study (iCVS) investigators Persistent endotheliopathy in the pathogenesis of long COVID syndrome&#x2014;Reply to comment from von Meijenfeldt et al. J. Thromb. Haemost. 2021;20:270&#x2013;271. doi: 10.1111/jth.15578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15578</ArticleId><ArticleId IdType="pmc">PMC8646468</ArticleId><ArticleId IdType="pubmed">34738307</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu-Bercu A., Kessler A., Groot R., Dragunaite B., Heightman M., Hillman T., Price L.C., Brennan E., Sivera R., Vanhoorelbeke K. Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. J. Thromb. Haemost. 2023;21:94&#x2013;100. doi: 10.1016/j.jtha.2022.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2022.10.013</ArticleId><ArticleId IdType="pmc">PMC9773628</ArticleId><ArticleId IdType="pubmed">36695401</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Ward S.E., Townsend L., Karampini E., Elliott S., Conlon N., Dunne J., Kiersey R., Naughton A., Gardiner M., et al. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J. Thromb. Haemost. 2022;20:2429&#x2013;2438. doi: 10.1111/jth.15830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15830</ArticleId><ArticleId IdType="pmc">PMC9349977</ArticleId><ArticleId IdType="pubmed">35875995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X.L. ADAMTS13 and von Willebrand Factor in Thrombotic Thrombocytopenic Purpura. Annu. Rev. Med. 2015;66:211&#x2013;225. doi: 10.1146/annurev-med-061813-013241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-061813-013241</ArticleId><ArticleId IdType="pmc">PMC4599565</ArticleId><ArticleId IdType="pubmed">25587650</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasannan N., Heightman M., Hillman T., Wall E., Bell R., Kessler A., Neave L., Doyle A., Devaraj A., Singh D., et al. Impaired exercise capacity in post&#x2013;COVID-19 syndrome: The role of VWF-ADAMTS13 axis. Blood Adv. 2022;6:4041&#x2013;4048. doi: 10.1182/bloodadvances.2021006944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021006944</ArticleId><ArticleId IdType="pmc">PMC9098525</ArticleId><ArticleId IdType="pubmed">35543533</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Meijenfeldt F.A., Havervall S., Adelmeijer J., Lundstr&#xf6;m A., Magnusson M., Mackman N., Thalin C., Lisman T. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021;5:756&#x2013;759. doi: 10.1182/bloodadvances.2020003968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003968</ArticleId><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Nougier C., Benoit R., Simon M., Desmurs-Clavel H., Marcotte G., Argaud L., David J.S., Bonnet A., Negrier C., Dargaud Y. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J. Thromb. Haemost. 2020;18:2215&#x2013;2219. doi: 10.1111/jth.15016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15016</ArticleId><ArticleId IdType="pmc">PMC7405476</ArticleId><ArticleId IdType="pubmed">32668058</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., Martin-Loeches I., Bannan C., Nadarajan P., Bergin C., O&#x2019;Farrelly C., Conlon N., Bourke N.M., et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J. Thromb. Haemost. 2021;19:1064&#x2013;1070. doi: 10.1111/jth.15267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunder A., Saha S., Kamath S., Kumar M. Vaccine-induced thrombosis and thrombocytopenia (VITT); Exploring the unknown. J. Fam. Med. Prim. Care. 2022;11:2231. doi: 10.4103/jfmpc.jfmpc_2259_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_2259_21</ArticleId><ArticleId IdType="pmc">PMC9254762</ArticleId><ArticleId IdType="pubmed">35800512</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele T., Ulm L., Holtfreter S., Sch&#xf6;nborn L., Kuhn S.O., Scheer C., Warkentin T.E., Br&#xf6;ker B.M., Becker K., Aurich K., et al. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2. Blood. 2021;138:299&#x2013;303. doi: 10.1182/blood.2021012217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012217</ArticleId><ArticleId IdType="pmc">PMC8129797</ArticleId><ArticleId IdType="pubmed">33988688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. COVID-19: Immunopathology and its implications for therapy. Nat. Rev. Immunol. 2020;20:269&#x2013;270. doi: 10.1038/s41577-020-0308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0308-3</ArticleId><ArticleId IdType="pmc">PMC7143200</ArticleId><ArticleId IdType="pubmed">32273594</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore B.J.B., June C.H. Cytokine release syndrome in severe COVID-19. Science. 2020;368:473&#x2013;474. doi: 10.1126/science.abb8925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragnoli B., Da Re B., Galantino A., Kette S., Salotti A., Malerba M. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence. Int. J. Mol. Sci. 2023;24:8945. doi: 10.3390/ijms24108945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24108945</ArticleId><ArticleId IdType="pmc">PMC10219009</ArticleId><ArticleId IdType="pubmed">37240292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R., Aktay-Cetin &#xd6;., Craddock V., Morales-Cano D., Kosanovic D., Cogolludo A., Perez-Vizcaino F., Avdeev S., Kumar A., Ram A.K., et al. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities. PLoS Pathog. 2023;19:e1011063. doi: 10.1371/journal.ppat.1011063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011063</ArticleId><ArticleId IdType="pmc">PMC9836319</ArticleId><ArticleId IdType="pubmed">36634048</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Yalavarthi S., Shi H., Gockman K., Zuo M., Madison J.A., Blair C.N., Weber A., Barnes B.J., Egeblad M., et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5:e138999. doi: 10.1172/jci.insight.138999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.138999</ArticleId><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil Extracellular Traps Kill Bacteria. Science. 2004;303:1532&#x2013;1535. doi: 10.1126/science.1092385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1092385</ArticleId><ArticleId IdType="pubmed">15001782</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 2018;18:134&#x2013;147. doi: 10.1038/nri.2017.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.105</ArticleId><ArticleId IdType="pubmed">28990587</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik T.J., Mohiddin S.A., Dimarco A., Patel V., Savvatis K., Marelli-Berg F.M., Madhur M.S., Tomaszewski M., Maffia P., D&#x2019;Acquisto F., et al. COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 2020;116:1666&#x2013;1687. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>George P.M., Reed A., Desai S.R., Devaraj A., Faiez T.S., Laverty S., Kanwal A., Esneau C., Liu M.K., Kamal F. A persistent neutrophil-associated immune signature characterizes post&#x2013;COVID-19 pulmonary sequelae. Sci. Transl. Med. 2022;14:eabo5795. doi: 10.1126/scitranslmed.abo5795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo5795</ArticleId><ArticleId IdType="pubmed">36383686</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Estes S.K., Ali R.A., Gandhi A.A., Yalavarthi S., Shi H., Sule G., Gockman K., Madison J.A., Zuo M., et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. 2020;12:eabd3876. doi: 10.1126/scitranslmed.abd3876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell M., Greene C., Connolly R., Brennan D., Laffan A., O&#x2019;Keeffe E., Zaporojan L., Connolly E., Cheallaigh C.N., Conlon N., et al. Blood-brain barrier disruption in Long COVID-associated cognitive impairment. Res. Sq. 2022. preprint .</Citation></Reference><Reference><Citation>Corman V.M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D.K., Bleicker T., Br&#xfc;nink S., Schneider J., Schmidt M.L., et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25:2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.3.2000045</ArticleId><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak G.C., Cheng P.K., Lau S.S., Wong K.K., Lau C., Lam E.T., Chan R.C., Tsang D.N. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J. Clin. Virol. 2020;129:104500. doi: 10.1016/j.jcv.2020.104500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104500</ArticleId><ArticleId IdType="pmc">PMC7278630</ArticleId><ArticleId IdType="pubmed">32585619</ArticleId></ArticleIdList></Reference><Reference><Citation>Broughton J.P., Deng X., Yu G., Fasching C.L., Servellita V., Singh J., Miao X., Streithorst J.A., Granados A., Sotomayor-Gonzalez A., et al. CRISPR&#x2013;Cas12-based detection of SARS-CoV-2. Nat. Biotechnol. 2020;38:870&#x2013;874. doi: 10.1038/s41587-020-0513-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0513-4</ArticleId><ArticleId IdType="pmc">PMC9107629</ArticleId><ArticleId IdType="pubmed">32300245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Yamahara K.M., Cao Y., Boehm A.B. Absolute Quantification of Enterococcal 23S rRNA Gene Using Digital PCR. Environ. Sci. Technol. 2016;50:3399&#x2013;3408. doi: 10.1021/acs.est.5b05747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.est.5b05747</ArticleId><ArticleId IdType="pubmed">26903207</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu A.S. Digital Assays Part I: Partitioning Statistics and Digital PCR. JALA J. Assoc. Lab. Autom. 2017;22:369&#x2013;386. doi: 10.1177/2472630317705680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2472630317705680</ArticleId><ArticleId IdType="pubmed">28448765</ArticleId></ArticleIdList></Reference><Reference><Citation>Pav&#x161;i&#x10d; J., &#x17d;el J., Milavec M. Assessment of the real-time PCR and different digital PCR platforms for DNA quantification. Anal. Bioanal. Chem. 2016;408:107&#x2013;121. doi: 10.1007/s00216-015-9107-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-015-9107-2</ArticleId><ArticleId IdType="pmc">PMC4706846</ArticleId><ArticleId IdType="pubmed">26521179</ArticleId></ArticleIdList></Reference><Reference><Citation>Dingle T.C., Sedlak R.H., Cook L., Jerome K.R. Tolerance of Droplet-Digital PCR vs Real-Time Quantitative PCR to Inhibitory Substances. Clin. Chem. 2013;59:1670&#x2013;1672. doi: 10.1373/clinchem.2013.211045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2013.211045</ArticleId><ArticleId IdType="pmc">PMC4247175</ArticleId><ArticleId IdType="pubmed">24003063</ArticleId></ArticleIdList></Reference><Reference><Citation>Whale A.S., Huggett J.F., Cowen S., Speirs V., Shaw J., Ellison S., Foy C.A., Scott D.J. Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res. 2012;40:e82. doi: 10.1093/nar/gks203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks203</ArticleId><ArticleId IdType="pmc">PMC3367212</ArticleId><ArticleId IdType="pubmed">22373922</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Cai Y., Li Z., Shen S., Sha M., Head S.R., Wang Y. A digital PCR assay development to detect EGFR T790M mutation in NSCLC patients. Front. Lab. Med. 2018;2:89&#x2013;96. doi: 10.1016/j.flm.2018.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.flm.2018.08.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Cai Y., Shen S., Sha M., Li Z., Head S.R., Wang Y. A digital PCR based assay to detect all ALK fusion species. Front. Lab. Med. 2018;2:49&#x2013;54. doi: 10.1016/j.flm.2018.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.flm.2018.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasudevan H.N., Xu P., Servellita V., Miller S., Liu L., Gopez A., Chiu C.Y., Abate A.R. Digital droplet PCR accurately quantifies SARS-CoV-2 viral load from crude lysate without nucleic acid purification. Sci. Rep. 2021;11:780. doi: 10.1038/s41598-020-80715-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80715-1</ArticleId><ArticleId IdType="pmc">PMC7804156</ArticleId><ArticleId IdType="pubmed">33436939</ArticleId></ArticleIdList></Reference><Reference><Citation>Alteri C., Cento V., Antonello M., Colagrossi L., Merli M., Ughi N., Renica S., Matarazzo E., Di Ruscio F., Tartaglione L., et al. Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients. PLoS ONE. 2020;15:e0236311. doi: 10.1371/journal.pone.0236311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236311</ArticleId><ArticleId IdType="pmc">PMC7478621</ArticleId><ArticleId IdType="pubmed">32898153</ArticleId></ArticleIdList></Reference><Reference><Citation>Falzone L., Musso N., Gattuso G., Bongiorno D., Palermo C., Scalia G., Libra M., Stefani S. Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection. Int. J. Mol. Med. 2020;46:957&#x2013;964. doi: 10.3892/ijmm.2020.4673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2020.4673</ArticleId><ArticleId IdType="pmc">PMC7388836</ArticleId><ArticleId IdType="pubmed">32705153</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahdi A., Zhao A., Fredengren E., Fedorowski A., Braunschweig F., Nygren-Bonnier M., Runold M., Bruchfeld J., Nickander J., Deng Q., et al. Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: A multi-omic profiling study. Sci. Rep. 2023;13:20230. doi: 10.1038/s41598-023-47539-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-47539-1</ArticleId><ArticleId IdType="pmc">PMC10658082</ArticleId><ArticleId IdType="pubmed">37981644</ArticleId></ArticleIdList></Reference><Reference><Citation>Longworth J., Dittmar G. An antigen microarray protocol for COVID-19 serological analysis. STAR Protoc. 2021;2:100815. doi: 10.1016/j.xpro.2021.100815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2021.100815</ArticleId><ArticleId IdType="pmc">PMC8387221</ArticleId><ArticleId IdType="pubmed">34462737</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Li Y., Zhang H., Wang W., Yang X., Qi H., Li H., Men D., Zhou J., Tao S. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses. Nat. Commun. 2020;11:3581. doi: 10.1038/s41467-020-17488-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17488-8</ArticleId><ArticleId IdType="pmc">PMC7360742</ArticleId><ArticleId IdType="pubmed">32665645</ArticleId></ArticleIdList></Reference><Reference><Citation>Omer A. MicroRNAs as powerful tool against COVID-19: Computational perspective. Wiley Interdiscip. Rev. Syst. Biol. Med. 2023;15:e1621. doi: 10.1002/wsbm.1621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wsbm.1621</ArticleId><ArticleId IdType="pubmed">37345625</ArticleId></ArticleIdList></Reference><Reference><Citation>Tribolet L., Kerr E., Cowled C., Bean A.G.D., Stewart C.R., Dearnley M., Farr R.J. MicroRNA Biomarkers for Infectious Diseases: From Basic Research to Biosensing. Front. Microbiol. 2020;11:1197. doi: 10.3389/fmicb.2020.01197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01197</ArticleId><ArticleId IdType="pmc">PMC7286131</ArticleId><ArticleId IdType="pubmed">32582115</ArticleId></ArticleIdList></Reference><Reference><Citation>De Gonzalo-Calvo D., Ben&#xed;tez I.D., Pinilla L., Carratal&#xe1; A., Moncus&#xed;-Moix A., Gort-Paniello C., Molinero M., Gonz&#xe1;lez J., Torres G., Bernal M., et al. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl. Res. 2021;236:147&#x2013;159. doi: 10.1016/j.trsl.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8149473</ArticleId><ArticleId IdType="pubmed">34048985</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum C., Loiselle J., Ahmed N., Shaw T.A., Toudic C., Pezacki J.P. MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19. Drugs. 2021;81:517&#x2013;531. doi: 10.1007/s40265-021-01474-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-021-01474-5</ArticleId><ArticleId IdType="pmc">PMC7910799</ArticleId><ArticleId IdType="pubmed">33638807</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>